Work

Safety and durability of ponatinib in patients with Philadelphia chromosome-positive (Ph+) leukemia: Long-term follow-up of an ongoing phase I study.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.7063

Authors: Michael J. Mauro, Jorge E. Cortes, Hagop M. Kantarjian, Neil P. Shah, Dale Bixby, Ian Flinn, Thomas O'Hare, Simin Hu, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, Brian J. Druker, Michael W. N. Deininger, Moshe Talpaz

Institutions: OHSU Knight Cancer Institute, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, University of Michigan, Sarah Cannon, Huntsman Cancer Institute, ARIAD Pharmaceuticals (United States)

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603378557

Cites:

Cited by: 4

Related to: 10